Journal
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Volume 378, Issue 3, Pages 582-587Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s00216-003-2238-x
Keywords
estrogen receptor; ER alpha; ER beta; endocrine-active compound; endocrine disruptor
Ask authors/readers for more resources
Estrogenic compounds exert pleiotropic effects in wildlife and humans, and endogenous estrogens, like 17beta-estradiol, regulate growth and development of their target tissues. Environmental, industrial, or naturally occurring chemicals that possess estrogenic and/or antiestrogenic activities are termed xenoestrogens and may interfere with endocrine systems. These xenoestrogens are therefore defined as endocrine-active or endocrine-disrupting compounds. The estrogen receptor (ER) is the major regulatory unit within the estrogen-signaling pathway and the molecular mechanisms of estrogen and ER actions are described briefly. Based on the mechanism of ER action, in vitro test systems are described that can be employed for screening but also for the elucidation of mechanisms of action of (anti)estrogenic compounds. How screening assays and mechanistic studies can aid in human risk assessment for potential endocrine-active compounds is discussed also.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available